# Clinical Genomics * **Definition:** The field of study that combines clinical practice with genomic information to improve patient care, particularly in the diagnosis, treatment, and monitoring of diseases such as cancer and inherited disorders. * **Taxonomy:** Specialties / Clinical Genomics ## News * Selected news on the topic of **Clinical Genomics**, for healthcare technology leaders * 4.5K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/19/2025 | [**STAT+: Regeneron to buy 23andMe out of bankruptcy for $256 million**](https://www.statnews.com/2025/05/19/23andme-regeneron-bankruptcy-genetic-testing-patient-data/?utm_campaign=rss) | [[STAT]] | | 5/19/2025 | [**Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services**](https://hitconsultant.net/2025/05/19/regeneron-to-acquire-key-23andme-assets-for-256m/) | [[HIT Consultant]] | | 4/18/2025 | [**Emerging Technologies that are Driving Significant Innovations in Digital Health and ...**](https://www.healthcareittoday.com/2025/04/18/emerging-technologies-that-are-driving-significant-innovations-in-digital-health-and-reshaping-patient-care-delivery/) | [[Healthcare IT Today]] | | 4/7/2025 | [**Top innovative projects at health systems - Becker's Hospital Review - Healthcare News & Analysis**](https://www.beckershospitalreview.com/innovation/top-innovative-projects-at-health-systems/) | [[Beckers Hospital Review]] | | 4/6/2025 | [**Top projects from Fortune's most innovative health systems**](https://www.beckershospitalreview.com/healthcare-information-technology/innovation/top-innovative-projects-at-health-systems/) | [[Beckers Hospital Review]] | | 3/9/2025 | [**AI in Healthcare: Minimum Requirements to Enter the Field - Medium**](https://medium.com/@hiya31/ai-in-healthcare-minimum-requirements-to-enter-the-field-eb76bf824895) | [[Medium]] | | 1/31/2025 | [**Deloitte Earns Top Recognition in Healthcare IT for AI, Cloud, and Digital Innovation, Black ...**](https://finance.yahoo.com/news/deloitte-earns-top-recognition-healthcare-194500093.html) | [[Yahoo Finance]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of ...**](https://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/20/2024 | [**Future Market Revenue for Healthcare Artificial Intelligence Projected at 13.1AGR from ...**](https://www.linkedin.com/pulse/future-market-revenue-healthcare-artificial-intelligence-9ndyc) | [[Linkedin]] | | 11/27/2024 | [**Patient Engagement Technology Market to grow by USD 37.41 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/patient-engagement-technology-market-to-grow-by-usd-37-41-billion-from-2024-2028--driven-by-rising-chronic-disease-cases-and-ais-impact-on-market-trends---technavio-302316647.html) | [[PR Newswire]] | | 11/26/2024 | [**Mount Sinai Center to Combine AI, Data Science, Genomics - Healthcare Innovation**](https://www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/55246083/mount-sinai-center-to-combine-ai-data-science-genomics) | [[Healthcare Innovation]] | | 11/25/2024 | [**Digi-Tech Pharma & AI Conference 2025: AI and Genomics Take Center Stage (London ...**](https://www.marketwatch.com/press-release/digi-tech-pharma-ai-conference-2025-ai-and-genomics-take-center-stage-london-united-kingdom-may-28-29-2025-researchandmarkets-com-2a20b074) | [[MarketWatch]] | | 11/14/2024 | [**AI in Healthcare Market to Grow by USD 20.34 Billion (2024-2028), Driven by ... - MarketWatch**](https://www.marketwatch.com/press-release/ai-in-healthcare-market-to-grow-by-usd-20-34-billion-2024-2028-driven-by-healthcare-digitization-ai-powered-report-highlights-market-transformation-technavio-ef87aa24) | [[MarketWatch]] | | 11/11/2024 | [**Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/population-health-management-market-to-grow-by-usd-22-55-billion-from-2024-2028--driven-by-rising-adoption-of-healthcare-it-report-with-ai-impact-on-trends---technavio-302300769.html) | [[PR Newswire]] | | 11/8/2024 | [**AI-driven precision healthcare is here - what you need to know**](https://www.healthcareitnews.com/news/ai-driven-precision-healthcare-here-what-you-need-know) | [[Healthcare IT News]] | | 11/7/2024 | [**Next-Generation Sequencing (NGS) Services Market is expected to generate a revenue of ...**](https://www.prnewswire.com/news-releases/next-generation-sequencing-ngs-services-market-is-expected-to-generate-a-revenue-of-usd-18-35-billion-by-2031--globally-at-21-25-cagr-verified-market-research-302298672.html) | [[PR Newswire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals) | [[Business Wire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics' Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals**](http://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 7/22/2024 | [**Robert T. Braithwaite, Channing Hamlet and Daniel A. Platt Share Insights on ... - Los Angeles Times**](https://www.latimes.com/business-insights/story/2024-07-22/robert-t-braithwaite-channing-hamlet-and-daniel-a-platt-share-insights-on-the-healthcare-biotech-and-life-sciences-landscape-in-2024) | [[LA Times]] | | 7/19/2024 | [**Texas A&M Health and Burst IQ Partner to Optimize Clinical Genomics Research -**](https://hitconsultant.net/2024/07/19/texas-am-health-and-burst-iq-partner-to-optimize-clinical-genomics-research/) | [[HIT Consultant]] | | 7/9/2024 | [**Clinical Genomics Market Dynamics: Key Trends, Challenges, and Market Forecast**](https://www.whatech.com/og/markets-research/medical/854041-clinical-genomics-market-dynamics-key-trends-challenges-and-market-forecast) | whatech.com | | 6/28/2024 | [**Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey**](http://www.businesswire.com/news/home/20240628892797/en/Genoks-and-Velsera-Forge-Strategic-Partnership-to-Revolutionize-Cancer-Diagnostics-in-Turkey/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 6/28/2024 | [**Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey**](http://www.businesswire.com/news/home/20240628892797/en/Genoks-and-Velsera-Forge-Strategic-Partnership-to-Revolutionize-Cancer-Diagnostics-in-Turkey/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **NeoGenomics**: A provider of cancer-focused genetic testing services, collaborating with ConcertAI on clinical research. - **BGI Genomics**: A global leader in precision medicine solutions, providing advanced genetic testing and analysis services. - **Foundation Medicine**: A leader in genomic profiling for cancer, offering insights that help guide treatment decisions. - **Genomics England**: Utilizes AWS's generative AI service to identify new gene associations linked to medical conditions, enhancing genetic testing and treatment. - **Cofactor Genomics**: A clinical-stage diagnostics company focusing on RNA decoding to bridge the precision medicine gap. - **Cleveland Clinic**: Engaged in AI collaborations to advance genomics and precision medicine. - **Quest Diagnostics**: A leading provider of diagnostic information services, specializing in clinical genomics and laboratory testing. - **Labcorp**: A leading global life sciences company that provides comprehensive clinical laboratory services and has recently expanded its genetic testing capabilities through acquisitions. - **Guardant Health**: Specializes in blood tests for cancer detection and monitoring, focusing on precision medicine through advanced genomic technologies. - **BioAI**: Collaborates with Genomic Testing Cooperative to enhance biomarker discovery using multimodal AI. - **GeneDx**: Introduced GeneDx Discover, a data visualization tool for biopharmaceutical companies to access deidentified genetic data, facilitating drug development. - **Telos PGX**: A leader in pharmacogenetic testing, recently acquired by Principle Health Systems to enhance personalized medication solutions. - **OneCell Diagnostics**: A genomics-based precision oncology company focused on making cancer diagnostic testing more accessible and actionable. - **LetsGetChecked**: A healthcare company focused on personalized healthcare solutions and genomic testing. - **Velsera**: A global healthcare technology firm offering the Clinical Genomics Workspace to enhance genomic analysis. - **Exact Sciences**: Awarded funding to enhance access to colorectal cancer screening, demonstrating commitment to improving patient outcomes through genetic testing. - **Genoks**: A Turkish genomics healthcare company partnering with Velsera to improve cancer diagnostics. - **Myriad Genetics**: A company focusing on innovation in oncology, women's health, and pharmacogenomics, with significant investments in labs and digital capabilities. ### Partnerships and Collaborations - **Epic and GeneDx**: Working together to integrate rapid whole genome sequencing into Epic's EHR system for improved genomic insights. - **ConcertAI and NeoGenomics**: Launched CTO-H, a software-as-a-service solution for hematological diseases, enhancing clinical trial design and research analytics. - **BioAI and Genomic Testing Cooperative**: This partnership aims to enhance biomarker discovery and diagnostics using AI and characterized imaging data. - **Genomics Plc and Vertex Pharmaceuticals**: Extended collaboration to discover and develop new precision medicines using proprietary genetic tools. - **Genoks and Velsera**: Integrating advanced genomic analysis technologies to improve cancer diagnostics in Turkey. - **BGI Genomics and Technopark Biogen**: Collaboration to open the Astana Genetic Center in Kazakhstan for early disease diagnosis and preventive medicine. - **Bumrungrad International Hospital and Golden Helix**: A multiyear agreement to enhance genomics initiatives focusing on cancer and hereditary disease diagnostics. - **Myriad Genetics and GSK/QIAGEN**: Strategic partnerships to enhance capabilities in HRD diagnostic testing. - **Cleveland Clinic and IBM**: A collaboration to advance medical research in genomics and precision medicine using AI. - **Unite Genomics and pharmaceutical partners**: A partnership to create a platform for unifying patient health information using AI. - **Inocras and SPI**: Introducing advanced genomic solutions to the Japanese market, focusing on whole-genome sequencing. - **DNAnexus and Galatea Bio**: Announced a strategic collaboration to enhance biomedical research and precision medicine for Latin American populations. - **Eli Lilly and Genetic Leap**: A partnership to develop genetic medicine therapeutics using RNA-targeted AI technology. - **Velsera and Diagnostic Longwood**: Enhancing NGS solutions in Spain and Portugal to accelerate precision medicine adoption. - **Guardant Health and Meaningful Insights Biotech Analytics (MiBA)**: This collaboration focuses on improving biomarker testing and data analytics for personalized cancer care. - **Mount Sinai Health System**: Established the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to integrate AI with genomics. - **Texas A&M Health and BurstIQ**: Utilizing the LifeGraph platform to enhance clinical research and patient interactions. - **Labcorp and Ballad Health**: A strategic collaboration aimed at enhancing outreach laboratory services in the Appalachian Highlands by acquiring select operating assets. - **Principle Health Systems and Telos PGX**: An acquisition to enhance personalized medication solutions in healthcare. ### Innovations, Trends, and Initiatives - **Clinical Genomics Advancements**: Non-invasive cell-free DNA testing for early detection of chromosomal abnormalities and improvements in newborn screening. - **Clinical Genomics Workspace**: A platform by Velsera designed to support oncology and inherited disease specialists. - **GeneDx Discover**: A pioneering tool providing access to genetic data for drug development, addressing inefficiencies in the current drug discovery process. - **CGW Plus**: An updated Clinical Genomics Workspace platform by Velsera that improves workflow efficiency and patient care quality through advanced genetic data analysis. - **Hyper-personalized Medicine**: An innovative approach tailoring treatments based on genetic makeup, environment, and lifestyle, driven by advancements in genomics and data analytics. - **LINQ Platform**: A lab automation platform that reduces manual errors and increases output in clinical genomics labs. - **CRISPR Technology**: Facilitating precise gene editing for treating genetic disorders, enhancing the capabilities of clinical genomics. - **Whole Genome and Exome Sequencing Market Growth**: Projected to grow significantly, driven by the demand for personalized medicine and advancements in genetic testing technologies. - **AI in Genomics**: The integration of AI technologies to enhance genomic data analysis and precision medicine. - **Cloud Computing and Blockchain**: Enhancing data management and security in genomic research and patient data handling. - **VarSome Clinical**: A platform automating the discovery and interpretation of NGS data, now CE marked for clinical use. - **AI in Precision Medicine**: Integrates advanced computational technologies to tailor treatments based on genetic, lifestyle, and environmental factors. - **PanOmiQ Platform**: An AI-powered platform achieving a 100% match in variant calling, showcasing advancements in genomic accuracy. - **CRISPR and Wearable Technology**: Technological advancements enhancing the personalization of healthcare through continuous monitoring and gene editing. - **AI-Driven Genomic Analysis**: Dr. Anmol Kapoor discusses the transformative potential of AI in genomic analysis and its integration with blockchain technology for secure data management. - **Multiomics**: The integration of various omics technologies is driving personalized medicine and drug discovery. - **EpiSign Technology**: Developed by Dr. Bekim Sadikovic, this technology uses epigenomic data to diagnose over 100 genetic diseases, showcasing advancements in rare disease diagnostics. - **LifeGraph Platform**: A blockchain-based platform that enhances clinical research by integrating various data types for comprehensive patient profiles. - **AI and Machine Learning**: Transforming precision medicine by enabling early disease classification and personalized treatment pathways. ### Challenges and Concerns - **Integration of Genomic Technologies**: The need for integrating innovative genomic technologies into clinical practice to provide personalized patient care. - **Interoperability Issues**: Challenges in integrating various genomic data systems can limit the effectiveness of precision medicine. - **Data Privacy and Security**: Ensuring patient privacy and data rights while enhancing clinical research and genomic data management. - **Regulatory Compliance**: Meeting stringent requirements under the EU's In-Vitro Diagnostic Medical Devices Regulation (IVDR) for genomic tools. - **Training Needs**: Extensive training required for healthcare professionals to effectively utilize precision medicine technologies. - **Implementation Costs**: High costs and interoperability issues hinder the widespread adoption of precision medicine software. - **High Implementation Costs**: The financial burden of adopting precision medicine technologies can hinder smaller healthcare institutions. - **Patient Privacy and Informed Consent**: Challenges in ensuring patient privacy while promoting responsible data sharing among clinicians and researchers. - **Regulatory Challenges**: The need for robust infrastructure and regulatory navigation as AI-powered precision medicine becomes more prevalent in healthcare. - **Data Fragmentation**: Hinders advancements in patient care and clinical research, obstructing early disease detection and personalized treatment interventions. - **Integration of AI**: Challenges in data security, standardization, and integration into clinical practices remain significant concerns. - **High Failure Rate in Drug Discovery**: Despite advancements in lab automation, the failure rate in new medicine discovery remains high. - **Bias in AI Models**: The need to address potential biases in AI applications to ensure equitable healthcare solutions. - **Data Security**: On-premise patient engagement solutions offer enhanced security but come with high costs and maintenance challenges. - **Data Security Risks**: Increased reliance on cloud services raises concerns about data breaches and loss of sensitive patient information. - **Healthcare Inequities**: Efforts are being made to address inequities in healthcare access and improve patient financial experiences. ## Related Topics [[Clinical Genetics]]; [[Laboratory Genomics]]; [[Genomics]]; [[Clinical Biochemical Genetics]]; [[Genetic Testing]]; [[Medical Genetics]]; [[Genomic Analysis]]; [[Laboratory Genetics]]; [[Clinical Cytogenetics]]